RxDoctor Payments Data

Punit Bhakta

Optometrist · Peachtree City, GANPI 1134405046

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.8%), consulting fees and entertainment — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 35.2% of the total. Reporting peaked in 2022 at $291 and has fallen 57.0% since, to $125 in 2025. That places this record below the midpoint for optometrist clinicians in GA, where the typical reported total is $813.

$700in general payments, 2019–2025

Across 22 payments — averaging $31.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$246
  • Johnson & Johnson Vision Care, Inc.$235
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$89
  • Alcon$51
  • Optos, Inc.$46
  • ABB Con-cise Optical Group LLC$18
  • plus $13 from 1 others

What the payments were for

  • Consulting fees$23534%
  • Food & beverage$41860%
  • Entertainment$467%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$700 in reported general payments places this provider in the 45th percentile of 1,285 optometrist providers in Georgia.

See all optometrist providers in Georgia →

Medicare billing

Part B allowed, 2024
$73,774
Medicare patients
447
Services billed
2,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine15$16,885
CombiganBrimonidine Tartrate/Timolol24$13,701
LumiganBimatoprost23$10,622
Latanoprost104$1,449
Timolol Maleate42$521
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat33$446
Prednisolone Acetate12$325
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13$95

Paid to pharmacies, not to this prescriber.

Other optometrist in Peachtree City

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →